| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO | /s/ James R. Oehler, Attorney-in-Fact | 24 Feb 2026 | 0001902866 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HALO | Common Stock | Options Exercise | $0 | +5,332 | +13% | $0.000000 | 47,257 | 20 Feb 2026 | Direct | |
| transaction | HALO | Common Stock | Tax liability | $204,138 | -2,876 | -6.1% | $70.98 | 44,381 | 20 Feb 2026 | Direct | F1 |
| transaction | HALO | Common Stock | Options Exercise | $0 | +7,011 | +16% | $0.000000 | 51,392 | 23 Feb 2026 | Direct | |
| transaction | HALO | Common Stock | Tax liability | $267,160 | -3,782 | -7.4% | $70.64 | 47,610 | 23 Feb 2026 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HALO | Restricted Stock Units | Options Exercise | $0 | -5,332 | -25% | $0.000000 | 15,995 | 20 Feb 2026 | Common Stock | 5,332 | $0.000000 | Direct | F3 |
| transaction | HALO | Restricted Stock Units | Options Exercise | $0 | -7,011 | -33% | $0.000000 | 14,022 | 23 Feb 2026 | Common Stock | 7,011 | $0.000000 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The reported disposition of 2,876 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| F2 | The reported disposition of 3,782 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| F3 | This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |